Point72 Asset Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.4M | Buy |
1,527,930
+1,414,075
| +1,242% | +$68.9M | 0.15% | 155 |
|
|
2025
Q1 | $2.45M | Buy |
113,855
+107,707
| +1,752% | +$2.32M | 0.01% | 774 |
|
|
2024
Q4 | $165K | Buy |
+6,148
| New | +$165K | ﹤0.01% | 1155 |
|
|
2024
Q2 | – | Sell |
-62,500
| Closed | -$1.15M | – | 1257 |
|
|
2024
Q1 | $1.15M | Hold |
62,500
| – | – | ﹤0.01% | 929 |
|
|
2023
Q4 | $993K | Hold |
62,500
| – | – | ﹤0.01% | 921 |
|
|
2023
Q3 | $1.18M | Hold |
62,500
| – | – | ﹤0.01% | 888 |
|
|
2023
Q2 | $1.41M | Hold |
62,500
| – | – | ﹤0.01% | 832 |
|
|
2023
Q1 | $1.59M | Sell |
62,500
-130,900
| -68% | -$3.32M | ﹤0.01% | 827 |
|
|
2022
Q4 | $2.93M | Hold |
193,400
| – | – | 0.01% | 717 |
|
|
2022
Q3 | $2.43M | Sell |
193,400
-16,600
| -8% | -$208K | 0.01% | 744 |
|
|
2022
Q2 | $2.05M | Hold |
210,000
| – | – | 0.01% | 749 |
|
|
2022
Q1 | $3.5M | Hold |
210,000
| – | – | 0.01% | 703 |
|
|
2021
Q4 | $5.33M | Buy |
+210,000
| New | +$5.33M | 0.02% | 610 |
|